semaglutide oral cardiovascular indication news 2025 soul Congreso ACC. 25: Semaglutide Reduces Events in People With Type 2 Diabetes With Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial semaglutide oral cardiovascular indication 2025

Who is a good candidate for medical weight management treatments

It does this by reducing appetite and caloric intake, which can be particularly beneficial for those struggling with obesitya common concern among middle-aged or older adults who frequent Nulevel Wellness Medspa

"2026 FEHB/PSHB Formulary." Zepbound (tirzepatide) listed at Tier 3/4 (specialty tier) for weight management indication with prior authorization

The authors of the study concluded that the GLP-1 receptor agonist lixisenatide had a three-point beneficial effect, when compared with placebo, in the change over a 12-month period from a baseline value of approximately 15 points on a 132-point scale measuring motor disability. The active arm improved 0.04 points in the lixisenatide group and worsened 3.04 points in the placebo group

In this blog, we will break down the weight loss timeline and explore what you can expect during your journey with these medications

Located at Door 6, 3S Building, San Pedro Street, just across My Hotel in Davao City, the new beauty nook offers products that promise to help bring out the natural beauty and skin of everyone